“Adhesion Barrier Market Report is set to have rapid growth due growing geriatric population, along with rising number of surgeries and sports-related injuries at global, regional and national level, influencing the industry trends in each of the sub-segments from 2019 to 2029”, says Visiongain Report

04 September 2019
Pharma

Visiongain has launched a new pharma report Adhesion Barrier Market Forecast 2019-2029 : By Product (Synthetic, Natural), By Application (Cardiovascular, Neurological), By Formulation (Film/Mesh, Gel), Regional and Segment Forecasts.

The global Adhesion Barrier market is poised for rapid growth between 2019 and 2029. The growth of the geriatric population, together with the growing number of sports-related surgeries and injuries, should drive the market. Even the increasing cases of chronic diseases, such as cancer and neurological, gynecological, ophthalmic and dental disorders, contribute to market demand.

The treatment of these diseases requires surgical procedures and microsurgery in some cases, which is increasing the demand for adhesion barriers. For example, the prevalence of cancer is increasing, according to statistics published by the World Health Organization (WHO). About 8.2 million die of cancer each year, which represents 13.0% of deaths worldwide.

The leading companies included in the Report are Johnson & Johnson; Sanofi S.A.; Baxter International, Inc.; Becton, Dickinson and Company; Integra LifeSciences Holdings Corporation; Anika Therapeutics, Inc.; Atrium Medical Corporation (A Part of Getinge Group); FzioMed, Inc.; MAST Biosurgery, Inc.; and Innocoll Holdings PLC.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 207 336 6100.

About Visiongain
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes RNA Analysis/Transcriptomics Market Report 2020-2030

Rising preference for personalised medicine in developed as well developing economies coupled with increasing investment by biotechnological and pharmaceutical companies for drug discovery is expected to increase RNA analysis/transcriptomics market concentration over the forecast period. In order to increase the reliability and success rate of the drug production process.

30 November 2020

Read

Visiongain Publishes Plasma Therapy Market Report 2021-2031

The market is forecasted for the next ten years based on market growth within each segment of the blood plasma products. The report study aims to explore the market drivers, restraints and also market opportunities facing blood plasma product stakeholders in different geographic areas.

26 November 2020

Read

Visiongain Publishes Precision Cancer Diagnostic Test Market Report 2021-2031

Molecular diagnostics are rapidly transforming drug development and patient selection: trials with biomarkers have higher success rates than those without, and combining patients with a proven biomarker allows efficient trials to be conducted in rare cancers.

26 November 2020

Read

Visiongain Publishes Top 50 Biosimilar Drug Manufacturers 2021

Growing demand for cost-effective drugs; rising prevalence of chronic diseases; mounting investment in drug R&D by biopharmaceutical companies; new product launches and rising acceptance of biosimilars in North America region are some of the major factors that propel the biosimilars market growth.

25 November 2020

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever